The payer will still hold a minority stake in the company but will use the acquired funds to repurchase stock, according to the Nov. 3 announcement.
“With more than 25 years of experience in home-based care, USMM has outperformed in numerous value-based care initiatives and consistently delivered lower costs, better health outcomes, and higher patient satisfaction ratings,” said Sarah London, vice chair of Centene’s board of directors. “We are confident this transaction will best position USMM to expand its reach and impact while helping Centene to deliver on our value creation plan.”
Rubicon Founders, Valtruis, Oak HC/FT and HLM Venture Partners will be purchasing Centene’s stake after federal clearance and other closing conditions.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
